Skip to main content

Oncoheroes Biosciences receives from FDA the Rare Pediatric Disease Designation (RPDD) to volasertib for rhabdomyosarcoma

< Back to news
 30.09.2020

Oncoheroes Biosciences receives from FDA the Rare Pediatric Disease Designation (RPDD) to volasertib for rhabdomyosarcoma